Palliative Prostate Artery Embolization for Prostate Cancer: A Case Series

Introduction Prostate artery embolization (PAE) is recognized as a treatment for lower urinary tract symptoms (LUTS) in men with benign prostatic hyperplasia. LUTS and urinary retention are common in men with prostate cancer (PCa). The purpose of this study was to estimate the efficacy and safety of...

Full description

Saved in:
Bibliographic Details
Published in:Cardiovascular and interventional radiology 2019-10, Vol.42 (10), p.1405-1412
Main Authors: Malling, B., Røder, M. A., Lindh, M., Frevert, S., Brasso, K., Lönn, L.
Format: Article
Language:English
Subjects:
Aged
Aged, 80 and over
Arterial Interventions
ARTERIES
ARTERIOSCLEROSIS
Atherosclerosis
Cancer
Cardiology
Clinical Investigation
CLINICAL TRIALS
Complications
Confidence intervals
Embolization
Embolization, Therapeutic - methods
Feasibility Studies
Humans
Hyperplasia
Imaging
Lower Urinary Tract Symptoms - complications
Lower Urinary Tract Symptoms - therapy
Male
Medical instruments
Medicine
Medicine & Public Health
Middle Aged
NCT
NCT03104907
NEOPLASMS
Nuclear Medicine
Palliation
Palliative Care - methods
PATIENTS
Prospective Studies
PROSTATE
Prostate cancer
Prostatic Neoplasms - complications
Quality
Radiology
RADIOLOGY AND NUCLEAR MEDICINE
RETENTION
Signs and symptoms
Statistical analysis
SYMPTOMS
Treatment Outcome
Ultrasound
Urinary Retention - complications
Urinary Retention - therapy
URINARY TRACT
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Introduction Prostate artery embolization (PAE) is recognized as a treatment for lower urinary tract symptoms (LUTS) in men with benign prostatic hyperplasia. LUTS and urinary retention are common in men with prostate cancer (PCa). The purpose of this study was to estimate the efficacy and safety of palliative PAE on LUTS or urinary retention in men with advanced PCa. Materials and methods This prospective, single-center trial was conducted from March 2017 to November 2018. The trial protocol was registered online (ClinicalTrials.gov Identifier: NCT03104907). Only men with advanced PCa suffering from LUTS or urinary retention were included. The primary outcome was the ability to void without a catheter and International Prostate Symptom Score (IPSS) in non-catheter-dependent patients. The paired t test was used to analyze changes from baseline with 95% confidence intervals (CI). A p value 
ISSN:0174-1551
1432-086X
DOI:10.1007/s00270-019-02227-4